WT1 expression in angiogenic tumours of the skin

Histopathology

Volumn 47, Issue 1, 2005, Pages 67-73

  Timár, József ^a   Meszaros L ^a   Orosz, Z ^a   Albini, A ^b   Raso E ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Angiosarcoma; Endothelial cell; Haemangioma; Immunohistochemistry; Kaposi sarcoma; mRNA; WT1

Indexed keywords

WT1 PROTEIN;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEMANGIOMA; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA EXTRACTION; SKIN BIOPSY; SKIN TUMOR; WILD TYPE;

ANTIGENS, CD34; CELL LINE; CELL LINE, TUMOR; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMANGIOMA; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, VASCULAR TISSUE; PROTEIN ISOFORMS; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; WT1 PROTEINS;

EID: 22144486607     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02169.x     Document Type: Article

References (18)

1. Wagner KD, Wagner N, Schedl A. The complex life of WT1. J. Cell Sci. 2003; 116; 1653-1658.
2. Ellisen LW. Regulation of gene expression by WT1 in development and tumorigenesis. Int. J. Hematol. 2002; 76; 110-116.
3. Hirose M. The role of Wilm's tumor genes. J. Med. Invest. 1999; 46; 130-140.
4. Ellisen LW, Carlesso N, Cheng T, Scadden DT, Haber DA. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J. 2001; 20; 1897-1909.
5. Maurer U, Brieger J, Wiedmann E, Mitrou PS, Hoelzer D, Bermann L. The Wilm's tumor gene is expressed in a subset of CD34+ progenitors and downregulated in the course of differentiation in vitro. Exp. Hematol 1997; 25; 945-950.
6. Suzuki Y, Hashimoto K, Crissman J, Kanzaki T, Nishiyama S. The value of blood group-specific lectin and endothelial associated antibodies in the diagnosis of vascular proliferations. J. Cutan. Pathol. 1986; 13; 408-419.
7. Gehling UM, Ergün S, Schumacher U et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95; 3106-3112.
8. Moore MAS. Putting the neo into neoangiogenesis. J. Ciin. Invest. 2002; 109; 313-213.
9. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and hamatopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev. Cancer 2002; 2; 826-835.
10. Logan KA, McNatty KP, Juengel JL. Expression of Wilm's tumor gene and protein localization during ovarian formation and follicular development in sheep. Biol. Reprod. 2003; 68; 635-643.
11. Natoli TA, Liu J, Eremina V et al A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J. Am. Soc. Nephrol 2002; 13; 2058-2067.
12. Wagner K-D, Wagner N, Bondke A et al. The Wilms' tumor suppressor WT1 is expressed in the coronary vasculature after myocardial infarction. FASEB J. 2002; 16; 117-119.
13. Tao-Cheng JH, Nagy Z, Brightman MW. Astrocytic orthogonal arrays of intramembranous particle assemblies modulated by brain endothelial cells in vitro. J. Neurocytol. 1990; 19; 143-153.
14. Albini A, Paglieri I, Orengo G et al. The beta core fragment of human choriogonadotrophin inhibits growth of Kaposi sarcoma derived cells and a new immortalized Kaposi sarcoma cell line. AIDS 1997; 11; 713-721.
15. Kovács L, Szende B, Elek G et al. Working experience with a new vacuum-accelerated microwave histoprocessor. J. Pathol. 1996; 180; 108-110.
16. Folpe AL, Veikkola T, Valtola R, Weiss SW. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod. Pathol. 2000; 13; 180-185.
17. Skobe M, Brown LF, Tognazzi K et al. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. J. Invest. Dermatol. 1999; 113; 1047-1053.
18. Miettinen M, Sarlömo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod. Pathol 2000; 13; 536-541.